Pathstone Family Office, LLC Syneos Health, Inc. Transaction History

Pathstone Family Office, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$25.32 - $51.45 $2,253 - $4,579	-89 Reduced 1.31%	6,717 $246,000
Q3 2022 Oct 23, 2023	SELL	$46.5 - $79.14 $196,323 - $334,129	-4,222 Reduced 40.58%	6,181 $291,000
Q3 2022 Nov 14, 2022	SELL	$46.5 - $79.14 $172,515 - $293,609	-3,710 Reduced 35.28%	6,806 $321,000
Q2 2022 Oct 23, 2023	BUY	$63.06 - $84.75 $656,013 - $881,654	10,403 New	10,403 $745,000
Q2 2022 Aug 15, 2022	BUY	$63.06 - $84.75 $30,710 - $41,273	487 Added 4.86%	10,516 $754,000
Q1 2022 May 16, 2022	BUY	$74.15 - $99.36 $2,521 - $3,378	34 Added 0.34%	10,029 $812,000
Q4 2021 Feb 14, 2022	BUY	$86.01 - $102.89 $9,375 - $11,215	109 Added 1.1%	9,995 $1.03 Million
Q3 2021 Nov 16, 2021	BUY	$84.7 - $96.31 $198,960 - $226,232	2,349 Added 31.17%	9,886 $865,000
Q2 2021 Aug 31, 2021	BUY	$76.44 - $89.57 $246,671 - $289,042	3,227 Added 74.87%	7,537 $674,000
Q1 2021 May 14, 2021	BUY	$67.36 - $80.76 $290,321 - $348,075	4,310 New	4,310 $327,000

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.